Okada H, Suzuki H, Kanno Y, Ikenaga H, Saruta T
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
J Cardiovasc Pharmacol. 1995 Oct;26(4):564-9. doi: 10.1097/00005344-199510000-00009.
To investigate the role of the renin-angiotensin system (RAS) on nephrosclerosis in salt-loaded, partially nephrectomized spontaneously hypertensive rats (SHR), we evaluated the effects of angiotensin II (ANGII) blockade on the progression of nephrosclerosis with an angiotensin type 1 receptor (AT1rec) antagonist [TCV-116 (TCV)] and an angiotensin-converting enzyme (ACE) inhibitor (enalapril) at the doses equivalent in reducing systemic blood pressure (BP). SHR were five/sixths nephrectomized and were fed a high-salt diet. In addition to being significantly preventive against an increase in systolic BP, both TCV and enalapril significantly attenuated the increases in proteinuria and the renal histopathological alterations. Transcription of AT1rec mRNA in the remnant kidney was enhanced with the progression of nephrosclerosis, but was inhibited by TCV as well as enalapril. In these aspects, there were no apparent differences between effects of TCV and enalapril. The RAS system plays an important role in nephrosclerosis in partially nephrectomized SHR despite a high-salt diet, and direct ANGII blockade certainly protected the kidney against hypertensive injury in this model.
为研究肾素 - 血管紧张素系统(RAS)在盐负荷、部分肾切除的自发性高血压大鼠(SHR)肾硬化中的作用,我们用血管紧张素1型受体(AT1rec)拮抗剂[TCV - 116(TCV)]和血管紧张素转换酶(ACE)抑制剂(依那普利),在降低系统血压(BP)等效剂量下,评估了血管紧张素II(ANGII)阻断对肾硬化进展的影响。将SHR进行五分之六肾切除,并给予高盐饮食。除显著预防收缩压升高外,TCV和依那普利均显著减轻蛋白尿增加及肾脏组织病理学改变。残余肾中AT1rec mRNA的转录随肾硬化进展而增强,但被TCV以及依那普利抑制。在这些方面,TCV和依那普利的作用无明显差异。尽管给予高盐饮食,RAS系统在部分肾切除的SHR肾硬化中起重要作用,并且在此模型中直接阻断ANGII确实保护肾脏免受高血压损伤。